Insulin aspart, recombinant Subcutaneous and Kitabis Pak
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Kitabis Pak and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tobramycin
Brand name: Bethkis, Kitabis Pak, Tobi, TOBI Podhaler
Synonyms: Kitabis Pak (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Kitabis Pak inhalation
- Insulin aspart, recombinant Subcutaneous-Klofensaid II
- Insulin aspart, recombinant Subcutaneous-Klonopin
- Insulin aspart, recombinant Subcutaneous-Klonopin Wafer
- Insulin aspart, recombinant Subcutaneous-Klonopin Wafers
- Insulin aspart, recombinant Subcutaneous-Klor-Con
- Kitabis Pak-Insulin degludec
- Kitabis Pak-Insulin Degludec (U-100) Prefilled Pens
- Kitabis Pak-Insulin Degludec (U-100) Vials
- Kitabis Pak-Insulin Degludec (U-200) Prefilled Pens
- Kitabis Pak-Insulin degludec and liraglutide
- Kitabis Pak-Insulin degludec and liraglutide Subcutaneous